dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 26, 2026

UPS (UPS) Q4 2024 Earnings Call Transcript

View original at finance.yahoo.com
UPS (UPS) Q4 2024 Earnings Call Transcript Image source: The Motley Fool. Date Thursday, January 30, 2025 at 8:30 a.m. ET Call participants Chief Executive Officer — Carol B…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • UPS is not a company that's shrinking, it's a company that's growing

    80% confidence
  • Global GDP will grow 2.5% in 2025 compared to 2024

    80% confidence
  • UPS expects no material financial impact from SurePost insourcing

    80% confidence
  • UPS will expand domestic operating margin in every quarter of 2025

    80% confidence
  • UPS is growing profit dollars, not just margin

    80% confidence
  • The small package market excluding Amazon will grow in low single digits in 2025

    80% confidence
  • Real exports and industrial production will grow 2% YoY in 2025

    80% confidence
  • UPS was concerned about service deterioration under new USPS operating model

    80% confidence
  • U.S. manufacturing is expected to be positive in Q1 2025 after 7 negative quarters

    80% confidence
  • UPS believes it is ahead of competitors in generative AI deployment

    80% confidence
  • The Amazon volume reduction was UPS's decision, not Amazon's request, to take control of UPS's destiny

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
UPS (UPS) Q4 2024 Earnings Call Transcript: Source | Via News | fr.via.news